Skip to content

Vaping and Smoking Withdrawal Project

A Controlled Evaluation of Abstinence-Induced Withdrawal and Motivation to Vape/Smoke Among Daily ENDS Users vs. Cigarette Smokers

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05772845
Acronym
VASP
Enrollment
370
Registered
2023-03-16
Start date
2023-02-14
Completion date
2026-11-30
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)

Brief summary

The proposed research, which will systematically and comprehensively characterize the withdrawal among daily vapers compared to daily smokers of combustible cigarettes, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence/abuse liability and contributing to the development of therapies for tobacco/nicotine use, the leading preventable cause of death in the US.

Detailed description

Withdrawal is a key, multi-faceted component of tobacco/nicotine dependence. Because withdrawal symptoms are theorized to drive relapse, facets of withdrawal (e.g., craving, negative affect) are the targets of most current and emerging treatments. Despite the central importance of withdrawal, and a voluminous literature on withdrawal from combustible cigarette smoking, little is known about withdrawal from electronic nicotine delivery systems (ENDS). To overcome critical barriers to progress in the field, the first-ever prospective, controlled comparison of abstinence-induced withdrawal between ENDS vapers and cigarette smokers is proposed. Participants will be 160 established daily vapers (including former smokers and dual users who smoke occasionally), 160 established daily smokers (including former vapers and dual users who vape occasionally), and (for exploratory comparisons) 50 established daily dual users, who smoke and vape daily. Participants will complete two 4-hour lab visits; the order of the ad lib use visit and the abstinent visit (which follows 24 hours of abstinence) will be randomized across participants. To advance knowledge of ENDS withdrawal, state-of-the-science, multi-measure, multi-method assessments of key withdrawal facets (negative affect, craving, difficulty concentrating, restlessness, sleep, and appetite, as well as anhedonia/positive affect and somatic effects) will be employed. For each facet, the hypothesis that withdrawal magnitude is lower among vapers compared to smokers will be tested. To inform theory and intervention development, the behavioral significance of ENDS withdrawal will also be evaluated, testing the hypotheses that abstinence will increase the motivation to vape/smoke and this group difference will be accounted for (mediated) by vaper/smoker differences in one or more withdrawal facets. Exploratory analyses will examine whether group differences in withdrawal are accounted for (mediate) by differential nicotine exposure, explore the role of individual differences (e.g., sex, rate of nicotine metabolism, expectancies), and examine differences among sub-groups of vapers. The impact of this much-needed, detailed characterization of withdrawal from ENDS is enhanced by the inclusion of a comparator of great public health significance, cigarette smoking. In addition, by characterizing the specific withdrawal facets that drive motivation to vape/smoke, the proposed work will identify promising intervention targets for subsequent treatment development efforts.

Interventions

Participants will be asked to abstain from all tobacco/nicotine for 24 hours prior to the visit

Participants will be asked to smoke/vape as usual during the 24 hours prior to the visit

Sponsors

State University of New York at Buffalo
Lead SponsorOTHER
Roswell Park Cancer Institute
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

All participants will complete two visits, one following 24-hour abstinence, the other while smoking/vaping as usual.

Eligibility

Sex/Gender
ALL
Age
21 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 6+ months of daily/near-daily nicotine vaping and/or cigarette smoking (to yield 160 vapers, 160 smokers, 50 dual users) * 200+ ng/mL cotinine on a commercially-available quick screen Current

Exclusion criteria

* intention to quit daily/near-daily vaping/smoking in the next month * current (2+ days out of the past 7) use of pipe tobacco, hookah/shisha, smokeless tobacco, dissolvable tobacco, nicotine pouches. For vaping group only, current (2+ days out of past 7) use of cigars, cigarillos, or filtered cigars that are filled with tobacco or a mix of tobacco and marijuana * current use of any smoking cessation medication * current severe substance dependence other than tobacco/nicotine (including cannabis; NIDA Modified ASSIST of 27+) * current (past 2 weeks) suicidal ideation with intent and/or plan * current antipsychotic medications or lifetime history of schizophrenia or bipolar disorder * pregnancy (intake urine screen) Original

Design outcomes

Primary

MeasureTime frameDescription
Snaith-Hamilton Pleasure Scale 2.52.5 hourstotal score
Questionnaire on Vaping Craving 0.50.5 hourstotal craving score
Questionnaire on Vaping Craving 2.52.5 hourstotal craving score
Questionnaire on Smoking Urges - Brief 0.50.5 hourstotal craving score
Questionnaire on Smoking Urges - Brief 2.52.5 hourstotal craving score
PhenX Toolkit Insomnia Severity Index 0.50.5 hours7-item scale (but item #5 is omitted because of the short time-frame), total score impairment and interference with daily functioning
PhenX Toolkit Insomnia Severity Index 2.52.5 hours7-item scale (but item #5 is omitted because of the short time-frame), total score impairment and interference with daily functioning
Restlessness ratings 0.50.5 hours3-item scale
Restlessness ratings 2.52.5 hours3-item scale
Restlessness and Agitation Questionnaire - Modified 0.50.5 hourstotal score on subset of behavioral indicators
Restlessness and Agitation Questionnaire - Modified 2.52.5 hourstotal score on subset of behavioral indicators
Minnesota Nicotine Withdrawal Scale - 0.50.5 hours17-item version with indicators of various withdrawal facets
Minnesota Nicotine Withdrawal Scale - 2.52.5 hours17-item version with indicators of various withdrawal facets
Positive and Negative Affect Scale - PA 0.50.5 hourspositive affect subscale score
Positive and Negative Affect Scale - PA 2.52.5 hourspositive affect subscale score
Positive and Negative Affect Scale - NA 0.50.5 hoursnegative affect subscale score
Positive and Negative Affect Scale - NA 2.52.5 hoursnegative affect subscale score
Snaith-Hamilton Pleasure Scale 0.50.5 hourstotal score
Wisconsin Smoking Withdrawal Scale - anger 0.50.5 hoursanger subscale score
Wisconsin Smoking Withdrawal Scale - anger 2.52.5 hoursanger subscale score
Wisconsin Smoking Withdrawal Scale - anx 0.50.5 hoursanxiety subscale score
Wisconsin Smoking Withdrawal Scale - anx 2.52.5 hoursanxiety subscale score
Wisconsin Smoking Withdrawal Scale - sad 0.50.5 hourssadness subscale score
Wisconsin Smoking Withdrawal Scale - sad 2.52.5 hourssadness subscale score
Wisconsin Smoking Withdrawal Scale - conc 0.50.5 hoursdifficulty concentrating subscale score
Wisconsin Smoking Withdrawal Scale - conc 2.52.5 hoursdifficulty concentrating subscale score
Wisconsin Smoking Withdrawal Scale - sleep 0.50.5 hourssleep subscale score
Wisconsin Smoking Withdrawal Scale - sleep 2.52.5 hourssleep subscale score
Wisconsin Smoking Withdrawal Scale - appetite 0.50.5 hoursappetite subscale score
Wisconsin Smoking Withdrawal Scale - appetite 2.52.5 hoursappetite subscale score
Mood and Physical Symptoms Scale - 0.50.5 hourssingle-item indicators of withdrawal facets
Mood and Physical Symptoms Scale - 2.52.5 hourssingle-item indicators of withdrawal facets
Identical Pair Continuous Performance Task~2 hoursSustained attention, or vigilance, is the ability to maintain alertness to detect infrequent target stimuli during a long, monotonous task (e.g., Mackworth, 1948). We will use a version of the identical-pairs continuous performance task (Cornblatt et al., 1988) in which participants attend to a series of 800 4-digit numbers on a computer monitor (100-ms stimulus duration; 1500-ms ISI). Participants are asked to press the keyboard space bar only when the stimulus is identical to the immediately preceding stimulus (10% targets; Cooper et al., 2020; Rhodes \& Hawk, 2016). Percent correct hits (target detections) is the primary outcome.
n-back working memory task~2 hoursThe n-back task (e.g., Strand et al., 2012; Rhodes \& Hawk, 2016) requires indicating whether each stimulus in a rapidly presented series matches the location of the stimulus presented n stimuli before (e.g., n=0,1,2). Stimuli are small grey circles (100 ms; 30% targets). The focus here is on conditions that place marked demands on the "central executive" by requiring ongoing mental manipulation (i.e., n=2; see Baddeley, 2003). Brief practice with a 1-back and 2-back will be followed by 2 100-trial blocks of the 2-back. Accuracy is the primary outcome.
Stop signal reaction time task~2 hoursWe will employ the stop-signal paradigm (Logan et al., 1984), which provides a relatively pure index response inhibition (e.g., Nigg, 2001). In our typical task (e.g., Hawk et al., 2018; Rhodes \& Hawk, 2016), participants button press to indicate whether the "go" signal (\<-- or --\>) is pointing left or right. After a brief "go" practice, the stop signal (100-ms tone) is introduced, and participants complete 3 64-trail bocks during with they are asked to respond as quickly as possible but to not respond on stop signal trials (25% of trials). The stop signal occurs after go signal onset and adjusts dynamically across trials to yield \~50% inhibition (Logan et al., 1997). The primary outcome is stop signal reaction time (SSRT), an estimate of the speed of inhibition.
kcal consumed3 hoursFat, protein, and carbohydrate calories, and total calories, consumed during the visit.
Hypothetical commodity purchase task - vaping intensity 0.50.5 hoursIntensity of demand
Hypothetical commodity purchase task - vaping intensity 2.52.5 hoursintensity of demand
Hypothetical commodity purchase task - vaping persistence 0.50.5 hourspersistence of demand
Hypothetical commodity purchase task - vaping persistence 2.52.5 hourspersistence of demand
Hypothetical commodity purchase task - smoking intensity 0.50.5 hoursintensity of demand
Hypothetical commodity purchase task - smoking persistence 0.50.5 hourspersistence of demand
Hypothetical commodity purchase task - smoking persistence 2.52.5 hourspersistence of demand
Choice Behavior Under Cued Conditions (CBUCC) Task - spend vape3 hoursSpending for vape puffs
Choice Behavior Under Cued Conditions (CBUCC) Task - spend cig3 hoursSpending for cigarette puffs
Choice Behavior Under Cued Conditions (CBUCC) Task - spend water3 hoursSpending for water control
Choice Behavior Under Cued Conditions (CBUCC) Task - crave vape3 hoursCraving for vape puffs
Choice Behavior Under Cued Conditions (CBUCC) Task - crave cig3 hoursCraving for cigarette puffs

Secondary

MeasureTime frameDescription
modified Cigarette evaluation questionnaire3.5 hourssubjective/sensory aspects of smoking
modified e-Cigarette evaluation questionnaire3.5 hourssubjective/sensory aspects of vaping
Heart rateassessed at ~30-minute intervalsHeart rate, in beats per minute
Somatic/side effect checklist0.5 hoursAssesses a range of somatic and psychological symptoms (e.g., headache, fatigue, anxiety)

Countries

United States

Contacts

CONTACTLarry Hawk, PhD
lhawk@buffalo.edu716-645-0192
PRINCIPAL_INVESTIGATORLarry Hawk, PhD

University at Buffalo

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026